NDC11 00069122402
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00069-1224-02 | 00069-1224 |
| 00069-1224-2 | 00069-1224 |
| 0069-1224-02 | 0069-1224 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Panzyga | IMMUNE GLOBULIN INTRAVENOUS (HUMAN) | Pfizer Laboratories Div Pfizer Inc | e2cc5ddf-119e-ade3-79c2-c712cfbee099 | 2025-05-08 | Boxed warning, Warnings, Adverse reactions | 0069-1224-02 0069-1224 00069122402 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.